R1

Corxel’s oral GLP-1 trial adds momentum. The real question is who these drugs will reach

Eight Patients Cannot Solve Alzheimer’s. They Can Tell Us What the Next Trial Must Prove.

The ICU Has a New Signal. It Is Not a Verdict.

Deep learning uncovers a new ECG biomarker for sudden cardiac death

The Trial Has Started. Now the System Has to Find the Children.

Bangladesh’s Dengue Alarm Is Already Ringing

Sleep is now cardiovascular prevention. Health systems still treat it like lifestyle advice

The GLP-1 boom still needs exercise policy

Fungal Disease Was Left Out of the AMR Fight
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
